CN EN
Core Life Science Hardware Platforms

HST GENOMICS bridges the gap between precision engineering and biology. Our independently developed sequencers, single-cell partition systems, and automation workstations provide a solid data foundation for research and clinical applications worldwide.

Sequencing Platforms

Featuring patented DNB nano-array technology with zero PCR error accumulation. We offer the flagship T-Series ultra-high-throughput system (up to 6TB daily output) and the G-Series benchtop system designed for quick-turn applications.

Learn Instrument Specs

Single-Cell & Spatial

Reveal the true heterogeneity of cells. The Helix-SC microfluidic controller supports high-efficiency capture of up to 80,000 cells per run; the Spatial-Map imaging system maps the tissue transcriptome at sub-cellular resolution.

Explore Chips & Systems

Library Prep Automation

From nucleic acid extraction to library prep. The HST-Prep workstation features integrated PCR thermocyclers, automatic barcode reading, digital LIMS tracking, and active aerosol containment.

Explore Automation Workstations

Selected multi-omics service solutions

Reshape the granularity of omics testing with cutting-edge independent equipment and gold standard quality control services

human genome sequencing

Human whole genome (WGS) and exome (WES) sequencing services provide high-precision mutation filtering and medical reference, delivered by CAP/CLIA dual-certified laboratories.

learn more

Transcriptome and single cells

High-definition single-cell transcriptome (scRNA-Seq) and full-length transcriptome technologies help analyze tumor heterogeneity and single-cell developmental lineages.

learn more

Mass spectrometry quantification and omics

Quantitative proteomics (DIA) and metabolome detection based on the Orbitrap high-resolution mass spectrometer, integrating the "gene-transcription-protein-metabolism" full-flow design.

learn more

Pharmaceutical company clinical practice and CDMO

Provides tumor immune marker screening, clinical trial patient enrollment testing, and companion diagnostic kit (CDx) co-development and production outsourcing services.

learn more

Industry-leading sequencing and omics hardware base

We believe that a powerful hardware platform is the cornerstone for ensuring the accuracy of life science data. Through continuous research and development, HST GENOMICS has built a hardware ecosystem covering ultra-high-throughput sequencing, single-cell manipulation and in-situ imaging.

  • T-Series ultra-high-throughput sequencing platform

    The daily data output exceeds 6 TB, supporting very large population cohorts and multi-omics censuses.

  • Helix-SC Single Cell Controller

    Stable sorting and labeling of up to 80,000 single cells based on high-precision droplet capture.

  • Spatial-Map spatial imaging system

    Localize whole transcriptome expression in situ at the subcellular level, retaining precise three-dimensional spatial information.

HST GENOMICS Technology Platform
Multi-omics technology service capabilities

HST GENOMICS adheres to rigorous academic indicators and internationally recognized quality standards to build a multi-omics dry and wet experimental base. We have established branch centers around the world and are committed to serving global research partners with advanced sequencing storage and computing capabilities.

We provide up to 100% quality control of all sample flows, strictly follow the security regulations of GDPR and HIPAA, and ensure the security of the physical and digital assets of every genetic data.

5,200+ articles
Global collaboration to publish academic results
1,500+item
Declaration and authorization of patented technology
120+
Business coverage countries and regions
12,000+name
Global team of scientists and engineers

Latest news and developments

Keep up to date with HST GENOMICS’ latest developments in product launches, academic achievements and corporate collaborations

T-Series
Product Release | Oct 12, 2023

HST GENOMICS launches new flagship T-Series sequencing system

The revolutionary throughput increase will bring about unlimited possibilities in the era when the cost of whole-genome sequencing for a single person drops to hundreds of yuan.

Pharma
Corporate Cooperation | Sep 28, 2023

HST GENOMICS Biotech announces strategic alliance with global multinational pharmaceutical giants

The two parties will carry out in-depth and mutually beneficial cooperation in the screening of targeted biomarkers for tumor immunity and the development of companion diagnostic pipelines.

Agriculture
Scientific Research Cases | Sep 15, 2023

Case study: Application of molecular marker platform to successfully analyze the maize stress resistance genome

The HST GENOMICS chip typing platform assisted the expert team in significantly shortening the number of breeding generations in the selection of drought-resistant strains.